Clopidogrel in CREDO after one year - UpToDate
Meta-Analysis of the Efficacy and Safety of Clopidogrel Plus Aspirin as Compared to Antiplatelet Monotherapy for the Prevention
8 European countries, 48 centres Stent implantation Double-blind randomisation n = 1005 Clopidogrel 300mg od Aspirin 325mg od Clopidogrel 75mg od Aspirin. - ppt download
The Emerging Role of the Platelet in the Progression and Management of Atherothrombotic Disease
Antiplatelet / Anticoagulant Therapy Evidence and Guidelines - ppt download
Review on trials of clopidogrel
Prevalence of Chronic Kidney Disease in Type 2 Diabetes: The Canadian REgistry of Chronic Kidney Disease in Diabetes Outcomes (CREDO) Study - Clinical Therapeutics
Effect of Addition of Clopidogrel to Aspirin on Mortality | Stroke
Figure 1 from Interpreting the CHARISMA study. What is the role of dual antiplatelet therapy with clopidogrel and aspirin? | Semantic Scholar
Patients With Prior Myocardial Infarction, Stroke, or Symptomatic Peripheral Arterial Disease in the CHARISMA Trial - ScienceDirect
Patient Selection and Clinical Outcomes in the STOPDAPT-2 Trial | Circulation: Cardiovascular Interventions
Should We Preload STEMI Patients with Antiplatelet Therapy? - ppt download
Periprocedural Stroke After Coronary Revascularization (from the CREDO-Kyoto PCI/CABG Registry Cohort-3) - American Journal of Cardiology
PPT - Early And Long Term Treatment With Clopidogrel In Coronary Artery Disease PowerPoint Presentation - ID:475326
Antiplatelet Therapy for the Secondary Prevention of Acute Coronary Syndrome
Setting the Stage: Achieving Acceptance for TAVR in All Patients With Severe AS | tctmd.com
Interventional Cardiology Board Review ppt download
The Evidence for Current Cardiovascular Disease Prevention Guidelines
AHAACC Guidelines for Secondary Prevention for Patients with
Patients With Prior Myocardial Infarction, Stroke, or Symptomatic Peripheral Arterial Disease in the CHARISMA Trial - ScienceDirect
Triple therapy: A review of antithrombotic treatment for patients with atrial fibrillation undergoing percutaneous coronary intervention - Journal of Cardiology
Application of the Academic Research Consortium High Bleeding Risk Criteria in an All-Comers Registry of Percutaneous Coronary Intervention | Circulation: Cardiovascular Interventions
Long-term effect of clopidogrel in patients with and without diabetes: A systematic review and meta-analysis of randomized controlled trials
Study flow. CABG indicates coronary artery bypass grafting; CREDO-Kyoto... | Download Scientific Diagram
